271 Shares in DaVita Inc. (NYSE:DVA) Purchased by SBI Securities Co. Ltd.

SBI Securities Co. Ltd. purchased a new position in DaVita Inc. (NYSE:DVA) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 271 shares of the company’s stock, valued at approximately $41,000.

A number of other large investors have also recently made changes to their positions in DVA. Franklin Resources Inc. lifted its holdings in DaVita by 134.6% during the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after purchasing an additional 31,502 shares in the last quarter. FMR LLC increased its position in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock worth $29,082,000 after purchasing an additional 154,061 shares during the last quarter. Atom Investors LP bought a new position in DaVita during the third quarter valued at $4,094,000. Assenagon Asset Management S.A. increased its position in DaVita by 201.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock valued at $11,159,000 after acquiring an additional 49,885 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new stake in shares of DaVita during the third quarter valued at $726,000. 90.12% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently issued reports on DVA shares. Cowen reissued a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays upped their price objective on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $166.33.

DaVita Trading Down 3.4 %

Shares of NYSE:DVA opened at $146.71 on Wednesday. DaVita Inc. has a 1 year low of $125.64 and a 1 year high of $179.60. The firm has a market capitalization of $11.74 billion, a price-to-earnings ratio of 13.66, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The business’s 50 day moving average price is $159.41 and its 200-day moving average price is $157.90.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.